Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage

World Journal of Gastroenterology

Volumn 11, Issue 26, 2005, Pages 4052-4060

  Blandizzi, Corrado ^a   Fornai, Matteo ^a   Colucci, Rocchina ^a   Natale, Gianfranco ^a   Lubrano, Valter ^b   Vassalle, Cristina ^b   Antonioli, Luca ^b   Lazzeri, Gloria ^a   Del Tacca, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Gastric injury; Lansoprazole; Non steroidal anti inflammatory drugs

Indexed keywords

COPPER SULFATE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; GLUTATHIONE; INDOMETACIN; KETOPROFEN; LANSOPRAZOLE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MESSENGER RNA; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG MECHANISM; GENE LOCATION; IN VITRO STUDY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ACID SECRETION; STOMACH LESION; STOMACH MUCOSA; STOMACH PROTECTION; TISSUE DISTRIBUTION;

EID: 24144473427     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i26.4052     Document Type: Article

References (40)

1. Wallace JL. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001; 15: 691-703
2. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Int J Tissue React 1998; 20: 3-15
3. Whittle BJ. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol 2003; 17: 301-313
4. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000; 119: 521-535
5. Pohle T, Brzozowski T, Becker JC, Van Der Voort IR, Markman A, Konturek SJ, Moniczewski A, Domschke W, Konturek JW. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther 2001; 15: 677-687
6. McCarthy DM. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. Best Pract Res Clin Gastroenterol 2001; 15: 755-773
7. Matheson AJ, Jarvis B. Lansoprazole: An update of its place in the management of acid-related disorders. Drugs 2001; 61: 1801-1833
8. Welage LS. Pharmacologic properties of proton pump inhibitors. Pharmacotherapy 2003; 23(10 Pt 2): 74S-80S
9. Blandizzi C, Natale G, Gherardi G, Lazzeri G, Marveggio MC, Colucci R, Carignani D, Del Tacca M. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig Dis Sci 1999; 44: 2039-2050
10. Tsuji S, Sun WH, Tsuji M, Kawai N, Kimura A, Kakiuchi Y, Yasumaru S, Komori M, Murata H, Sasaki Y, Kawano S, Hori M. Lansoprazole induces mucosal protectio through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J Pharmacol Exp Ther 2002; 303: 1301-1308
11. Wallace JL, Granger DN. The cellular and molecular basis of gastric mucosal defence. FASEB J 1996; 10: 731-740
12. Takeuchi K, Mizoguchi H, Araki H, Komoike Y, Suzuki K. Lack of gastric toxicity of nitric oxide-releasing indomethacin, NCX-530, in experimental animals. Dig Dis Sci 2001; 46: 1805-1818
13. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham M, Cirino G. A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol 1994; 257: 249-255
14. Avila JR, De la Lastra CA, Martin MJ, Motilva V, Luque I, Delgado I, Esteban J, Herrerias J. Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicain in rats. Inflamm Res 1996; 45: 83-88
15. De la Lastra CA, Nieto A, Martin MJ, Cabre F, Herrerias JM, Motilva V. Gastric toxicity of racemic ketoprofen and its enatiomers in rat: Oxygen radical generation and COX expression. Inflamm Res 2002; 51: 51-57
16. Natale G, Lazzeri G, Blandizzi G, Gherardi G, Lenzi P, Pellegrini A, Del Tacca M. Seriate histomorphometry of whole rat stomach: An accurate and reliable method for quantitative analysis of mucosal damage. Toxicol Appl Pharmacol 2001; 174: 17-26
17. Pacheco I, Michiro O, Jin M, Sasahara H, Iwabuchi A, Odashima M, Konishi N, Wada I, Masamune O, Watanabe S. Corticosteroid pretreatment prevents small intestinal lesions induced by acetic acid-perfusion model in rats. Dig Dis Sci 2000; 45: 2337-2346
18. Tashima K, Fujita A, Takeuchi K. Aggravation of ischemia/reperfusion-induced gastric lesions in streptozotocin-diabetic rats. Life Sci 2000; 67: 1707-1718
19. Blandizzi C, Gherardi G, Marveggio C, Natale G, Carignani D, Del Tacca M. Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats. Digestion 1995; 56: 220-229
20. Lubrano V, Vassalle C, Blandizzi C, Del Tacca M, Palombo C, L'Abbate A, Boldi S, Natali A. The effects of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. Eur J Clin Invest 2003; 33: 117-125.
21. Kwicien S, Brzozowski T, Konturek SJ. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol 2002; 53: 39-50.
22. Szabo S. Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol 1991; 13(Suppl 2): S21-S34
23. Loguercio C, Di Pierro M. The role of glutathione in the gastrointestinal tract: A review. Ital J Gastroenterol Hepatol 1999; 31: 401-407
24. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radical Res 1999; 31: 273-300
25. Anthony A, Sim R, Dhillon AP, Pounder RE, Wakefield AJ. Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat. Gut 1996; 39: 363-368
26. Lehmann F, Hildebrand P, Beglinger C. New molecular targets for treatment of peptic ulcer disease. Drugs 2003; 63: 1785-1797
27. Janssen M, Dijkmans BA, Vandenbroucke JP, Biemond I, Lamers CB. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use. Dig Dis Sci 1994; 39: 362-365
28. Scarpignato C, Pelosini I. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Ital J Gastroenterol Hepatol 1999; 31(Suppl 1): S63-S72
29. Lapenna D, De Gioia S, Ciofani G, Festi D, Cuccurullo F. Antioxidant properties of omeprazole. FEBS Lett 1996; 382: 189-192
30. Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, Ishii H. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radical Biol Med 1996; 21: 727-731
31. Agastya G, West BC, Callahan JM. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol 2000; 22: 357-372
32. Wandall JH. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b245. Gut 1992; 33: 617-621
33. Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H. Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J Clin Gastroenterol 1995; 20(Suppl 2): S93-S96
34. Manjari V, Das UN. Oxidant stress, anti-oxidants, nitric oxide and essential fatty acids in peptic ulcer disease. Prostagl Leukotr Essent Fatty Acids 1998; 59: 401-406
35. Savoye G, Miralles-Barrachina O, Dechelotte P, Belmonte-Zalar L, Brung-Lefebvre M, Zalar A, Hochain P, Herve S, Colin R, Lerebours E, Ducrotte P. Low levels of gastric mucosal glutathione during upper gastric bleeding associated with the use of nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol 2001; 13: 1309-1313
36. Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, Blandizzi C, Del Tacca M. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: Role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol 2004; 195: 62-72
37. Fukuda T, Arakawa T, Shimizu Y, Ohtani K, Higuchi K, Kobayashi K. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa. J Clin Gastroenterol 1995; 20(Suppl 2): S5-S7
38. Ota S, Takahashi M, Yoshiura K, Hata Y, Kawabe T, Terano A, Omata M. Antiulcer drugs and gastric prostaglandin E2: An in vitro study. J Clin Gastroenterol 1993; 17(Suppl 1): S15-S21
39. Tanaka A, Hase S, Miyazawa T, Takeuchi K. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: A key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J Exp Pharmacol Ther 2002; 300: 754-761
40. Lee M, Kallal SM, Feldman M. Omeprazole prevents indomethacin-induced gastric ulcers in rabbits. Aliment Pharmacol Ther 1996; 10: 571-576